Mitsubishi UFJ Trust & Banking’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-92,731
| Closed | -$22.8M | – | 1208 |
|
|
2022
Q3 | $22.8M | Buy |
92,731
+511
| +0.6% | +$138K | 0.06% | 323 |
|
|
2022
Q2 | $22.8M | Sell |
92,220
-72,080
| -44% | -$19.5M | 0.06% | 342 |
|
|
2022
Q1 | $54.4M | Sell |
164,300
-1,461
| -0.9% | -$450K | 0.12% | 183 |
|
|
2021
Q4 | $59.5M | Sell |
165,761
-7,487
| -4% | -$2.53M | 0.12% | 186 |
|
|
2021
Q3 | $56.4M | Sell |
173,248
-4,112
| -2% | -$1.39M | 0.12% | 189 |
|
|
2021
Q2 | $55.4M | Sell |
177,360
-15,603
| -8% | -$4.79M | 0.12% | 204 |
|
|
2021
Q1 | $61.5M | Sell |
192,963
-6,896
| -3% | -$2.21M | 0.14% | 188 |
|
|
2020
Q4 | $64.8M | Sell |
199,859
-7,190
| -3% | -$1.99M | 0.13% | 193 |
|
|
2020
Q3 | $57.4M | Sell |
207,049
-5,978
| -3% | -$1.72M | 0.13% | 189 |
|
|
2020
Q2 | $51.5M | Sell |
213,027
-2,980
| -1% | -$598K | 0.12% | 195 |
|
|
2020
Q1 | $31.4M | Sell |
216,007
-109
| -0.1% | -$18.1K | 0.09% | 245 |
|
|
2019
Q4 | $36.9M | Buy |
216,116
+4,248
| +2% | +$788K | 0.09% | 261 |
|
|
2019
Q3 | $37.7M | Buy |
211,868
+22,189
| +12% | +$4.8M | 0.1% | 247 |
|
|
2019
Q2 | $49.4M | Buy |
189,679
+42,838
| +29% | +$11.4M | 0.17% | 129 |
|
|
2019
Q1 | $41.9M | Buy |
146,841
+897
| +0.6% | +$298K | 0.15% | 144 |
|
|
2018
Q4 | $47.4M | Sell |
145,944
-11,422
| -7% | -$3.97M | 0.2% | 115 |
|
|
2018
Q3 | $70.8M | Sell |
157,366
-142,026
| -47% | -$56M | 0.25% | 91 |
|
|
2018
Q2 | $122M | Buy |
299,392
+662
| +0.2% | +$240K | 0.21% | 108 |
|
|
2018
Q1 | $86.9M | Sell |
298,730
-11,280
| -4% | -$2.86M | 0.15% | 148 |
|
|
2017
Q4 | $58.1M | Sell |
310,010
-11,430
| -4% | -$2.13M | 0.1% | 225 |
|
|
2017
Q3 | $54.2M | Sell |
321,440
-8,460
| -3% | -$1.28M | 0.1% | 231 |
|
|
2017
Q2 | $47.3M | Sell |
329,900
-3,440
| -1% | -$462K | 0.09% | 258 |
|
|
2017
Q1 | $41.7M | Buy |
333,340
+80,100
| +32% | +$9.28M | 0.08% | 278 |
|
|
2016
Q4 | $28.5M | Sell |
253,240
-38,320
| -13% | -$4.44M | 0.06% | 364 |
|
|
2016
Q3 | $37.5M | Buy |
291,560
+1,170
| +0.4% | +$140K | 0.08% | 297 |
|
|
2016
Q2 | $31.7M | Sell |
290,390
-11,600
| -4% | -$1.15M | 0.07% | 325 |
|
|
2016
Q1 | $28.6M | Buy |
301,990
+82,280
| +37% | +$6.95M | 0.06% | 340 |
|
|
2015
Q4 | $19.8M | Buy |
+219,710
| New | +$18.6M | 0.05% | 448 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Mitsubishi UFJ Trust & Banking's ABMD Position: Q4 2022 in Review
Mitsubishi UFJ Trust & Banking sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 92,731 shares — an estimated $22.8M sold.
Mitsubishi UFJ Trust & Banking first reported a position in ABMD in Q4 2015 and held it in 28 quarters. The position peaked at $122M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Mitsubishi UFJ Trust & Banking reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Mitsubishi UFJ Trust & Banking sold 92,731 Abiomed Inc shares in Q4 2022, an estimated $22.8M.
- Mitsubishi UFJ Trust & Banking first reported a position in Abiomed Inc in Q4 2015 and held it in 28 quarters.
- Mitsubishi UFJ Trust & Banking's Abiomed Inc position peaked at $122M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q4 2022, filed 10 Feb 2023.